[HTML][HTML] Cetuximab relative dose intensity (RDI) in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): first observational prospective …
J Guigay, F Peyrade, B Petre-Lazar, F Mornex… - Annals of …, 2014 - Elsevier
Aim: Cetuximab combined with platinum is the standard first-line therapy in patients (pts)
with R/M SCCHN. DIRECT is the first multicenter prospective observational study evaluating …
with R/M SCCHN. DIRECT is the first multicenter prospective observational study evaluating …
[HTML][HTML] Cetuximab Relative Dose Intensity (Rdi) in Recurrent/Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (Scchn): First Observational …
J Guigay, F Peyrade, B Petre-Lazar… - Annals of …, 2014 - annalsofoncology.org
Aim: Cetuximab combined with platinum is the standard first-line therapy in patients (pts)
with R/M SCCHN. DIRECT is the first multicenter prospective observational study evaluating …
with R/M SCCHN. DIRECT is the first multicenter prospective observational study evaluating …